No Data
No Data
10-Q: Quarterly report
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
Q4 2023 Biofrontera Inc Earnings Call
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
Biofrontera Misses Q2 Top and Bottom Line Estimates; Reaffirms FY23 Outlook
Biofrontera Inc. Announces Voting Results From 2022 Annual Meeting of Stockholders
WOBURN, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced the final voting results
No Data